Development of the technology for obtaining PLGA and dipropoxybateriopurpurinimide-based nanoparticles. Evaluation of physicochemical and biological properties of the obtained delivery system

The article describes the process of developing a technology for producing nanoparticles based on a copolymer of lactic and glycolic acids (PLGA) containing dipropoxybacteriopurpurinimide (DPBPI) for photodynamic therapy of malignant tumors of various origins. Technological parameters for optimizing the method in order to obtain nanoparticles with specified characteristics are presented in this paper. As a result, the nanoparticles sample with an average particle diameter of 222.6±2.8 nm; ξ-potential 26.3±4.61 mV; polydispersity index 0.144; the total content of DPBPI in PLGA-DPBPI nanoparticles 13.6% were obtained. In accordance with the developed technique, the batch of PLGA-DPBPI nanoparticles was developed for further biological studies. In vitro experiments on A549 human non-small cell lung carcinoma for DPBPI, delivered as a part of PLGA-DPBPI nanoparticles, and an EL cremophor-based emulsion (CrEL-DPBPI) showed a similar intracellular distribution (concentrated in vesicular cell structures and diffusely distributed in cytoplasm), as well as high photo induced activity and the absence of dark cytotoxicity in case of PLGA-DPBPI nanoparticles. The study of the PLGA-DPBPI nanoparticles specific activity in vivo on the S37 mouse soft tissue sarcoma model showed the selective accumulation of DPBPI in tumor tissue and the almost complete elimination of DPBPI from the body within 48 hours, as well as significant antitumor efficacy in PDT.

1. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrinand caveolae-mediated endocytosis, Biochem. J., 2004, no. 377, pp. 159–169.

2. Sapelnikov M.D., Panov A.V., Nikolskaya E.D., Grin M.A. Development of delivery systems for highly effective photosensitizers applicable for photodynamic therapy of cancer, Biopharmatsevticheskiy jurnal, 2018, vol. 10, no 1, pp. 14–25. (in Russian)

3. Nikolskaya E., Sokol M., Faustova M., Zhunina O., Mollaev M., Yabbarov N., Tereshchenko O., Popov R., Severin E. The comparative study of influenceof lactic and glycolic acids copolymers type on propertiesof daunorubicin loaded nanoparticles and drug release, Acta of Bioeng. and Biomech., 2018, vol. 20, no. 1, pp. 65 –77.

4. Pantyushenko I.V., Grin M.A., Yakubovskaya R.I., Plotnikova E.A., Morozova N.B., Tsygankov A.A., Mironov A.F. A novel highly effective IR photosensitizer in the bacteriochlorophyll A series for photodynamic therapy of cancer, Vestnik MITHT, 2014, vol. 9, no. 3, pp. 3–10. (in Russian)

5. Prilozhenie A k Evropeyskoy konventsii ob ohrane pozvonochnyh zhivotnyh, ispol'zuemyh dlya eksperimentov i v drugih nauchnyh tselyah (ETS 123) [Appendix A of the European convention for the protection of vertebrate animals used for experimental and other scientific purposes (ETS No. 123)], 13 p. Available at: https://rm.coe.int/168007a6a8 (accessed 26.02.2019)

6. Rukovodstvo po soderzhaniyu i uhodu za laboratornymi zhivotnymi (stat'ya №5 konventsii) [Guidelines for the maintenance and care of laboratory animals (Article 5 of the Convention)], transl. by Krasilnischikova М.S., Belozertseva I.V. Saint-Petersburg, 2014. 102 p. Available at: http://ruslasa.ru/wp-content/uploads/2017/06/Приложение-А-к-ETS.pdf (accessed 26.02.2019)

7. Yakubovskaya R.I., Kazachkina N.I., Karmakova T.A., et al. Methodical recommendations on the study of photoinduced antitumor properties of drugs. In: Guide to conducting preclinical studies of medicines. Edited by A.N. Mironov. Moscow, Grif& Ko Publ., 2012, pp. 657–71. (in Russian)

8. Feofanov A., Grichine A., Karmakova T., Plyutinskaya A., Lebedeva V., Filyasova A., Yakubovskaya R., Mironov A., Egret-Charlier M., Vigny P. Near-infrared photosensitizer based on a cycloimide derivative of chlorin p6: 13,15-N-(3′-hydroxypropyl)cycloimide chlorin p6, Photochem. Photobiol., 2002, no. 75, pp. 633–643.

9. Nazarova A., Ignatova A., Feofanov A., Karmakova T., Pljutinskaya A., Mass O., Grin M., Yakubovskaya R., Mironov A., Maurizot J-C. 13,15-N-cycloimide derivatives of chlorin p6 with isonicotinyl substituent are photosensitizers targeted to lysosomes, Photochem. Photobiol. Sci., 2007, no. 6, pp. 118 4 –119 6.

10. Efremenko A.V., Ignatova A.A., Borsheva A.A., Grin M.A., Bregadze V.I., Sivaev I.B., Mironov A.F., Feofanov A.V. Cobalt bis(dicarbollide) versus closo-dodecaborate in boronated chlorin e6 conjugates: implications for photodynamic and boron-neutron capture therapy, Photochem. Photobiol. Sci., 2012, vol. 11, no. 4, pp. 645–652.

11. Loi S., Rischin D., Michael M., Yuen K., Stokes K.H., Ellis A.G., Millward M.J., Webster L.K. A randomized cross-over trial to determine the effect of Cremophor EL on the pharmacodynamics and pharmacokinetics of carboplatin chemotherapy, Cancer Chemother. Pharmacol., 2004, vol. 54, no. 5, pp. 407–414.